These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 28003840)
1. Lovastatin prevents bleomycin-induced DNA damage to HepG2 cells. Nasiri M; Etebari M; Jafarian-Dehkordi A; Moradi S Res Pharm Sci; 2016 Dec; 11(6):470-475. PubMed ID: 28003840 [TBL] [Abstract][Full Text] [Related]
2. Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide. Damrot J; Nübel T; Epe B; Roos WP; Kaina B; Fritz G Br J Pharmacol; 2006 Dec; 149(8):988-97. PubMed ID: 17088865 [TBL] [Abstract][Full Text] [Related]
3. Genotoxicity of environmental agents assessed by the alkaline comet assay. Møller P Basic Clin Pharmacol Toxicol; 2005; 96 Suppl 1():1-42. PubMed ID: 15859009 [TBL] [Abstract][Full Text] [Related]
4. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase from Haloferax volcanii: purification, characterization, and expression in Escherichia coli. Bischoff KM; Rodwell VW J Bacteriol; 1996 Jan; 178(1):19-23. PubMed ID: 8550415 [TBL] [Abstract][Full Text] [Related]
5. Lovastatin enhances the genotoxicity of doxorubicin in Chinese hamster V79 cells via noncovalent DNA binding. Snyder RD Drug Chem Toxicol; 2009; 32(1):17-20. PubMed ID: 19514934 [TBL] [Abstract][Full Text] [Related]
6. In vitro myotoxicity of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, pravastatin, lovastatin, and simvastatin, using neonatal rat skeletal myocytes. Masters BA; Palmoski MJ; Flint OP; Gregg RE; Wang-Iverson D; Durham SK Toxicol Appl Pharmacol; 1995 Mar; 131(1):163-74. PubMed ID: 7878672 [TBL] [Abstract][Full Text] [Related]
7. Suppression of lymphoid cell function in vitro by inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by lovastatin. Cutts JL; Bankhurst AD Int J Immunopharmacol; 1989; 11(8):863-9. PubMed ID: 2515162 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of protective effect of amifostine on dacarbazine induced genotoxicity. Etebari M; Jafarian-Dehkordi A; Lame V Res Pharm Sci; 2015; 10(1):68-74. PubMed ID: 26430459 [TBL] [Abstract][Full Text] [Related]
9. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in the rat ileum: effects of bile acids and lovastatin. Nguyen LB; Shefer S; Salen G; Ness GC; Batta A; Chowdhary IR; Paroulek E; Hauser S Metabolism; 1994 Nov; 43(11):1446-50. PubMed ID: 7968602 [TBL] [Abstract][Full Text] [Related]
10. Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase induce reductase accumulation and altered lamellar bodies in rat forestomach keratinocytes. Singer II; Kawka DW; Scott S; Bailey P; Kloss MW; Majka J; MacDonald JS Arterioscler Thromb; 1991; 11(5):1156-65. PubMed ID: 1911702 [TBL] [Abstract][Full Text] [Related]
11. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice. Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106 [TBL] [Abstract][Full Text] [Related]
12. Lovastatin prevents cisplatin-induced activation of pro-apoptotic DNA damage response (DDR) of renal tubular epithelial cells. Krüger K; Ziegler V; Hartmann C; Henninger C; Thomale J; Schupp N; Fritz G Toxicol Appl Pharmacol; 2016 Feb; 292():103-14. PubMed ID: 26739623 [TBL] [Abstract][Full Text] [Related]
13. Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Rogers JD; Zhao J; Liu L; Amin RD; Gagliano KD; Porras AG; Blum RA; Wilson MF; Stepanavage M; Vega JM Clin Pharmacol Ther; 1999 Oct; 66(4):358-66. PubMed ID: 10546919 [TBL] [Abstract][Full Text] [Related]
14. Effects of different inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, pravastatin sodium and simvastatin, on sterol synthesis and immunological functions in human lymphocytes in vitro. Kurakata S; Kada M; Shimada Y; Komai T; Nomoto K Immunopharmacology; 1996 Aug; 34(1):51-61. PubMed ID: 8880225 [TBL] [Abstract][Full Text] [Related]
15. Mevalonate prevents lovastatin-induced apoptosis in medulloblastoma cell lines. Wang W; Macaulay RJ Can J Neurol Sci; 1999 Nov; 26(4):305-10. PubMed ID: 10563217 [TBL] [Abstract][Full Text] [Related]
16. Increase in serum and bile cholesterol and HMG-CoA reductase by lovastatin in rats. Yamauchi S; Linscheer WG; Beach DH Am J Physiol; 1991 Apr; 260(4 Pt 1):G625-30. PubMed ID: 2018137 [TBL] [Abstract][Full Text] [Related]
17. Lack of correlation between 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and lovastatin resistance in nerve growth factor treated PC-12 cells. Marom M; Ben-Baruch G; Roitelman J; Kloog Y Cell Mol Neurobiol; 1994 Apr; 14(2):119-32. PubMed ID: 7842472 [TBL] [Abstract][Full Text] [Related]
18. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells. Choi JW; Jung SE J Pharmacol Exp Ther; 1999 Apr; 289(1):572-9. PubMed ID: 10087052 [TBL] [Abstract][Full Text] [Related]
19. The lipid lowering drug lovastatin protects against doxorubicin-induced hepatotoxicity. Henninger C; Huelsenbeck J; Huelsenbeck S; Grösch S; Schad A; Lackner KJ; Kaina B; Fritz G Toxicol Appl Pharmacol; 2012 May; 261(1):66-73. PubMed ID: 22712078 [TBL] [Abstract][Full Text] [Related]
20. Effect of HMG-CoA reductase inhibitors on extracellular matrix expression in human vascular smooth muscle cells. Riessen R; Axel DI; Fenchel M; Herzog UU; Rossmann H; Karsch KR Basic Res Cardiol; 1999 Oct; 94(5):322-32. PubMed ID: 10543307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]